Lymphoid Leukemia — Trials

Lymphoid Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

3,262 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 827
Recruiting: 465
Ph III recruiting: 43
Growth YoY: −7.8%
Industry share: 18%
Top sponsor: City of Hope Medical Center
Termination share: 33.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (489)

clinicaltrialsPublishedShowing 301–305 of 305 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01744223	Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant	active not recruiting	Phase 1 / Phase 2	36	Bellicum PharmaceuticalsINDUSTRY	1	Jul 12, 2022	clinicaltrials
NCT03301168	Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant	active not recruiting	Phase 1 / Phase 2	120	Bellicum PharmaceuticalsINDUSTRY	1	Jul 12, 2022	clinicaltrials